Susceptibility testing of 96 clinical group IVe isolates to 19 antimicrobial agents by agar dilution revealed that, at drug levels achievable in serum, the isolates were susceptible only to aminoglycosides, cephalosporins, and colistin, whereas at drug concentrations attainable in urine, they were susceptible to erythromycin, tetracycline, and nitrofurantoin as well.
In a 2-year study at a major Veterans Administration hospital, group IVe organisms were isolated in significant numbers from the urinary tracts of 72 patients. Of these patients, 90%o had spinal cord injuries and only 1 of the 72 patients did not have some form of long-term urinary drainage system. Fourteen of the patients had symptomatic urinary tract infections, whereas the remaining 58 patients were asymptomatic.
Although the presence of group IVe bacteria in human urine has previously been reported (13) , the (13) .
For determination of MICs, group IVe isolates were grown overnight on blood agar, inoculated onto Mueller-Hinton broth, and incubated for 5 to 6 h at 35C. This suspension was adjusted to a MacFarland turbidity standard of 0.5, diluted 1:10 in Mueller-Hinton broth, and inoculated with a Steers replicator (12) onto Mueller-Hinton agar containing twofold-increasing concentrations of antimicrobial agents. Horse blood (5%) was added to trimethoprimsulfamethoxazole Mueller-Hinton agar plates for optimal endpoint reading (3, 4 cin, cefoxitin, cephalothin, cefotaxime, kanamycin, and moxalactam. Two isolates were resistant to colistin (MIC, >16 jig/ml), and one isolate was resistant to gentamicin (MIC, >8 ,ug/ml). At concentrations of antimicrobial agents achievable in urine, the group IVe isolates were susceptible to erythromycin and tetracycline. These latter two agents are found in the urine at concentrations of up to 2,000 (5) and 500 (12) ,ug/ml, respectively. Nitrofurantoin (active drug in urine from 25 to 300 ,ug/ml [1, 9] ) had an MIC90 of 128 ,ug/ml. Hence, group IVe isolates are fairly susceptible to nitrofurantoin at concentrations achievable in urine. Chloramphenicol (MIC90, 32 ,ug/ml) would also probably be an effective antimicrobial agent against group IVe bacteria, having concentrations achievable in urine of from 10 to 670 ,g/ml (7). Against nalidixic acid, 18% of the isolates were resistant at concentrations of 128 ,ug/ml, with an MIC90 of 256 j.g/ml. With mean active concentrations of nalidixic acid in urine ranging from 75 (8) to 250 (2) ,ug/ml, substantial resistance against this agent is evident.
Of 26 clinical isolates of group IVe bacteria obtained by the Centers for Disease Control, 23 were from urine specimens; the sources of the remaining three were unknown (13) . From the susceptibility patterns reported here and the apparent exclusive isolation of group IVe from urine, it would appear that antimicrobial agents capable of attaining urine levels in excess of the MIC90 should be considered for therapy.
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